Short answer · Medically reviewed summary · Last updated: 2026-05-08
Livedoid vasculopathy is currently classified under the ICD-10 code L95.0 (Livedoid vasculitis), while it does not have a unique, dedicated code in the ICD-9 system, often being categorized under 709.8 (Other specified disorders of skin) or 446.2 (Hypersensitivity angiitis). These codes are used primarily for administrative and insurance purposes to document this chronic, painful occlusive vasculopathy of the skin. What is the clinical nature of Livedoid vasculopathy? Livedoid vasculopathy is a rare, chronic, occlusive skin disease characterized by recurrent, painful ulcers on the lower extremities, specifically the ankles and dorsum of the feet.
ICD10 code of Livedoid vasculopathy and ICD9 code
ICD-10 and ICD-9 codes for Livedoid vasculopathy, with classification details for clinicians, coders and patients.
Livedoid vasculopathy is currently classified under the ICD-10 code L95.0 (Livedoid vasculitis), while it does not have a unique, dedicated code in the ICD-9 system, often being categorized under 709.8 (Other specified disorders of skin) or 446.2 (Hypersensitivity angiitis). These codes are used primarily for administrative and insurance purposes to document this chronic, painful occlusive vasculopathy of the skin.
What is the clinical nature of Livedoid vasculopathy?
Livedoid vasculopathy is a rare, chronic, occlusive skin disease characterized by recurrent, painful ulcers on the lower extremities, specifically the ankles and dorsum of the feet. These ulcers often heal with characteristic ivory-white, star-shaped scars known as atrophie blanche. The condition is driven by microvascular thrombosis rather than true vasculitis, leading to ischemia and tissue necrosis. At DiseaseMaps.org, we currently support 15 members navigating the daily challenges of Livedoid vasculopathy, providing a platform for shared experiences in managing chronic pain and wound care.
How is Livedoid vasculopathy diagnosed?
Diagnosis of Livedoid vasculopathy is primarily clinical, supported by skin biopsy and histopathology. Because it is a diagnosis of exclusion, clinicians must rule out other systemic conditions. The diagnostic process typically includes:
- Skin biopsy: Showing hyalinizing vasculopathy with fibrin thrombi in the superficial and mid-dermal vessels.
- Laboratory screening: Testing for thrombophilic states, such as Factor V Leiden, protein C or S deficiency, and antiphospholipid syndrome.
- Dermatoscopic examination: Observing porcelain-white areas and telangiectatic vessels within the lesions.
What are the primary treatment goals for Livedoid vasculopathy?
Management of Livedoid vasculopathy focuses on preventing new thrombi and promoting the healing of existing ulcers. Because Livedoid vasculopathy is often recurrent, treatment plans are long-term. Common therapeutic approaches include antiplatelet agents (like aspirin or dipyridamole), anticoagulants (like rivaroxaban or warfarin), and in refractory cases, off-label use of intravenous immunoglobulin (IVIG) or danazol.
Next steps
- Consult a board-certified dermatologist or a vascular specialist familiar with Livedoid vasculopathy to discuss anti-thrombotic therapy.
- Maintain a symptom diary to track the frequency of ulcerations, which can help your physician adjust your medication dosage.
- Join the Livedoid vasculopathy community on DiseaseMaps.org to connect with others managing this condition.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.
References
- Orphanet (ORPHA:319690) - Livedoid vasculopathy.
- NIH GARD (Genetic and Rare Diseases Information Center) - Livedoid vasculopathy overview.
- PubMed/NCBI - Clinical management of Livedoid vasculopathy: A review of current therapies.
- DermNet NZ - Livedoid vasculopathy (Livedo vasculitis).
